Posts tagged tldr journal club
The tl;dr Pharmacy Journal Club: Voxelotor in Sickle Cell Disease (HOPE Trial)
The tl;dr Pharmacy Journal Club: Voxelotor in Sickle Cell Disease (HOPE Trial)

It’s journal club time! If you've been paying attention to the news this week, you probably saw that Pfizer is voluntarily withdrawing Oxbryta (voxelotor) from the market due to safety concerns. This is an inherent (and unfortunate) risk for drugs approved under the FDA's accelerated approval pathway. Even though the drug itself bit the dust, this journal club still holds up!

Read More
Clinical, Pharmacy School, Practice, ResidencyCourtney Howellsickle cell disease, hemoglobin S, vasoocclusive crisis, voxelotor, journal club, what is sickle cell anemia, sickle cell disease pharmacy, sickle cell disease for pharmacists, sickle cell management, sickle cell treatment, sickle cell anemia, sickle cell pathophysiology, what is hemoglobin, hemoglobin vs hemoglobin S, complications of sickle cell anemia, sickle cell complications, treatment of sickle cell disease, sickle cell anemia treatment, HOPE trial journal club, voxelotor journal club, tldr journal club
The tl;dr Pharmacy Journal Club: Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (COMPASS)
The tl;dr Pharmacy Journal Club: Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (COMPASS)

This is our first ever journal club, so let us know what you think about it! Shoot me a line at brandon@tldrpharmacy.com. If there's enough interest, we may do more of these journal clubs in the future.

Read More
Clinical, Pharmacy School, Practice, ResidencyBrandon Dysonxarelto, rivaroxaban, COMPASS trial, COMPASS journal club, tldr journal club, tl;dr journal club, aspirin, anticoagulation, biostats, biostatistics, literature evaluation, ARR, absolute risk reduction, journal club, statistics